Moleculin Biotech, Inc. MBRX
$0.61
+7.16%
at last close
Analyst Consensus
- Consensus Rating
- Buy (1 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $22.00
- Implied Upside
- +3493.6%
- Price Target Range
- $22.00 – $22.00
- Analysts (12 mo)
- 1
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-03-24 | HC Wainwright & Co.Sara Nik |
Reiterates | Buy | $22 |
| 2025-12-11 | HC Wainwright & Co.Sara Nik |
Maintains | Buy | $4 → $22 |
| 2025-09-10 | HC Wainwright & Co.Sara Nik |
Reiterates | Buy | $4 |
| 2025-08-27 | HC Wainwright & Co.Sara Nik |
Reiterates | Buy | $4 |
| 2025-06-18 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $4 |
| 2025-06-09 | HC Wainwright & Co.Joseph Pantginis |
Assumes | Buy | $4 |
| 2025-03-25 | Maxim GroupJason McCarthy |
Upgrades | Hold → Buy | $4 |
| 2025-03-25 | HC Wainwright & Co.Vernon Bernardino |
Reiterates | Buy | $8 |
| 2025-03-24 | HC Wainwright & Co.Vernon Bernardino |
Reiterates | Buy | $8 |
| 2025-03-03 | HC Wainwright & Co.Vernon Bernardino |
Maintains | Buy | $8 |
| 2024-11-12 | Maxim GroupJason McCarthy |
Maintains | Buy | $20 → $8 |
| 2024-04-12 | Roth MKMJonathan Aschoff |
Maintains | Buy | $40 |
| 2024-03-26 | Maxim GroupJason McCarthy |
Maintains | Buy | $45 → $20 |
| 2023-12-14 | HC Wainwright & Co.Vernon Bernardino |
Initiates coverage on | Buy | $45 |
| 2023-04-18 | Roth MKMJonathan Aschoff |
Maintains | Buy | $240 |
| 2023-03-24 | OppenheimerJeff Jones |
Reiterates | Outperform | $75 |
| 2022-07-18 | OppenheimerJeff Jones |
Assumes | Outperform | $30 → $210 |
| 2019-10-17 | Oppenheimer |
Initiates coverage on | Outperform | $180 |
| 2018-11-14 | Maxim Group |
Initiates coverage on | Buy | — |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $0.61
- Market Cap
- $4.35 million
- 52-Week Range
- $0.16 – $24.00
- Average Volume
- 1.58 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.